Synthaverse SA GPW:SVE:
Q1 NET LOSS 3.6 MILLION ZLOTYS
Q1 REVENUE 13.6 MILLION ZLOTYS
Q1 OPERATING LOSS 0.7 MILLION ZLOTYS
Synthaverse Q1 Net Loss 3.6 Million Zlotys
SYNTHAVERSE Spolka Akcyjna on 6ix
Story so far
Earlier from SYNTHAVERSE Spolka Akcyjna
- Synthaverse Receives Marketing Authorization For Onko BCG Medicinal Product In Ecuador
- Synthaverse Gets Marketing Authorization For Onko BCG In Serbia
- Synthaverse Appoints Artur Chodkowski As CEO
- Synthaverse Q3 Net Loss 7.7 Million Zlotys
- Synthaverse Receives Marketing Authorization For Onko BCG Drug In The Netherlands
Later from SYNTHAVERSE Spolka Akcyjna
All SYNTHAVERSE Spolka Akcyjna news releasesFollow SYNTHAVERSE Spolka Akcyjna into a list and get an email when it puts out news.
Follow SYNTHAVERSE Spolka Akcyjna